Wave Life Sciences Ltd.
WVENASDAQHealthcare● Active
$5.78
+$0.05(+0.79%)
Market Cap$1.1B
P/E Ratio—
52W High$21.73
52W Low$5.02
Wave Life Sciences Ltd. (WVE) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
WVE · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 28, 2026EPS Actual
-$0.13
Est. -$0.34 · +61.8%
Revenue
$0.04B
Est. $0.01B · +352.6%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 28, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
WVE reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.40
Rev. $5.46B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.40
Rev. Est.$5.46B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | -$0.31 | — | — | — | $0.01B | — |
| ▲ Q2 FY2026 | Apr 28, 2026 | -$0.34 | -$0.13 | +61.8% | $0.04B | $0.01B | +352.6% |
| ▼ Q1 FY2026 | Feb 26, 2026 | -$0.28 | -$0.30 | -7.1% | $0.02B | $0.02B | +7.4% |
| ▼ Q4 FY2025 | Nov 10, 2025 | -$0.30 | -$0.32 | -6.7% | $0.01B | $0.02B | -53.5% |
| ▼ Q3 FY2025 | Jul 30, 2025 | -$0.29 | -$0.31 | -6.9% | $0.01B | $0.01B | -11.7% |
| ▼ Q2 FY2025 | May 8, 2025 | -$0.27 | -$0.29 | -7.4% | $0.01B | $0.01B | -36.4% |
| ▲ Q1 FY2025 | Mar 4, 2025 | -$0.17 | $0.17 | +200.0% | $0.08B | $0.01B | +588.3% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -$0.28 | -$0.47 | -67.9% | $-0.01B | $0.03B | -130.0% |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
-$0.31
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 28, 2026Beat
EPS Actual
-$0.13
EPS Est.
-$0.34
EPS Surpr.
+61.8%
Revenue
$0.04B
Q1 FY2026
Feb 26, 2026Miss
EPS Actual
-$0.30
EPS Est.
-$0.28
EPS Surpr.
-7.1%
Revenue
$0.02B
Q4 FY2025
Nov 10, 2025Miss
EPS Actual
-$0.32
EPS Est.
-$0.30
EPS Surpr.
-6.7%
Revenue
$0.01B
Q3 FY2025
Jul 30, 2025Miss
EPS Actual
-$0.31
EPS Est.
-$0.29
EPS Surpr.
-6.9%
Revenue
$0.01B
Q2 FY2025
May 8, 2025Miss
EPS Actual
-$0.29
EPS Est.
-$0.27
EPS Surpr.
-7.4%
Revenue
$0.01B
Q1 FY2025
Mar 4, 2025Beat
EPS Actual
$0.17
EPS Est.
-$0.17
EPS Surpr.
+200.0%
Revenue
$0.08B
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
-$0.47
EPS Est.
-$0.28
EPS Surpr.
-67.9%
Revenue
$-0.01B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.70 | $-0.40 | $-0.01 | 6 |
| Q3 FY2027 | $-0.67 | $-0.39 | $-0.01 | 3 |
| Q2 FY2027 | $-0.68 | $-0.39 | $-0.01 | 5 |
| Q1 FY2027 | $-0.66 | $-0.38 | $-0.01 | 3 |
| Q4 FY2026 | $-0.58 | $-0.33 | $-0.01 | 6 |
| Q3 FY2026 | $-0.33 | $-0.32 | $-0.30 | 8 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 4 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 5 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 4 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 4 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 8 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 9 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 28, 2026 | +61.8% | $6.94 | $7.52 | +8.36% |
| ▼ Q1 FY2026 | Feb 26, 2026 | -7.1% | $14.54 | $15.36 | +5.64% |
| ▼ Q4 FY2025 | Nov 10, 2025 | -6.7% | $7.86 | $7.05 | -10.31% |
| ▼ Q3 FY2025 | Jul 30, 2025 | -6.9% | $8.32 | $8.16 | -1.92% |
| ▼ Q2 FY2025 | May 8, 2025 | -7.4% | $6.49 | $6.54 | +0.77% |
| ▲ Q1 FY2025 | Mar 4, 2025 | +200.0% | $10.05 | $11.23 | +11.74% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -67.9% | $16.44 | $15.89 | -3.35% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -19.1% | $5.98 | $5.74 | -4.01% |
Q2 FY2026+8.36%
Report Date
Apr 28, 2026
EPS Beat/Miss
+61.8%
Price Before
$6.94
Price After
$7.52
Q1 FY2026+5.64%
Report Date
Feb 26, 2026
EPS Beat/Miss
-7.1%
Price Before
$14.54
Price After
$15.36
Q4 FY2025-10.31%
Report Date
Nov 10, 2025
EPS Beat/Miss
-6.7%
Price Before
$7.86
Price After
$7.05
Q3 FY2025-1.92%
Report Date
Jul 30, 2025
EPS Beat/Miss
-6.9%
Price Before
$8.32
Price After
$8.16
Q2 FY2025+0.77%
Report Date
May 8, 2025
EPS Beat/Miss
-7.4%
Price Before
$6.49
Price After
$6.54
Q1 FY2025+11.74%
Report Date
Mar 4, 2025
EPS Beat/Miss
+200.0%
Price Before
$10.05
Price After
$11.23
Q4 FY2024-3.35%
Report Date
Nov 12, 2024
EPS Beat/Miss
-67.9%
Price Before
$16.44
Price After
$15.89
Q3 FY2024-4.01%
Report Date
Aug 8, 2024
EPS Beat/Miss
-19.1%
Price Before
$5.98
Price After
$5.74
Avg Beat Reaction+10.05%
Avg Miss Reaction-2.20%
Beat Rate2 / 8 quarters
Largest Move+11.74% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: WVE ends December
Wave Life Sciences Ltd. (WVE) most recently reported earnings on April 28, 2026 for Q2 FY2026, posting EPS of $-0.13 — beating the analyst consensus of $-0.34 by +61.8%. The next WVE earnings date is expected around September 1, 2026.
Each quarter, investors track WVE earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. WVE revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
WVE's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
WVE earnings · 5 questionsWave Life Sciences Ltd.'s next earnings report is expected around September 1, 2026. WVE typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; WVE historically reports after market close (AMC).
WVE earnings datewhen is WVE earningsWVE next earnings datewhen does WVE report earningsWVE earnings calendar
▸ Source: FMP · Wave Life Sciences Ltd. SEC filings · US GAAP · Wave Life Sciences Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026